Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)

Contract Value

Not provided

Codes & Classification
Solicitation Number

ARPA-H-SOL-26-160

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Classification Code

AN13

Additional Details
Set Aside

None

Place of Performance

District of Columbia, UNITED STATES

SourceSAM
The Advanced Research Projects Agency for Health (ARPA-H), operating under the Department of Health and Human Services and the National Institutes of Health, has issued a solicitation titled "Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening" (Procurement Identifier: ARPA-H-SOL-26-160). This procurement seeks innovative solutions to advance the development of a near real-time, non-destructive, AI-enabled system for screening pharmaceutical products and their inputs through packaging at ports of entry and other critical supply-chain nodes. The FASTPASS program is designed to address the growing need for rapid and reliable screening technologies that can ensure the integrity and safety of pharmaceuticals as they move through complex global supply chains. The envisioned system will leverage artificial intelligence to analyze products without opening their packaging, thereby preserving product integrity while enabling efficient and effective detection of potential threats or anomalies. The ultimate goal is to enhance the security and reliability of pharmaceutical supply chains, supporting public health and safety. Key requirements for this solicitation include the development and demonstration of advanced screening technologies that are non-destructive, capable of near real-time operation, and can be integrated into existing supply-chain workflows at ports of entry and other nodes. Solutions must utilize AI or machine learning methodologies to interpret data and provide actionable insights. Offerors are expected to provide a comprehensive cost proposal, as outlined in the solicitation's appendices, and adhere to the revised instructions and templates provided in Amendment 01. This amendment specifically updates the Cost Proposal Narrative Model and corrects minor typographical errors in the cost proposal workbook, ensuring clarity and accuracy in proposal submissions. The procurement is classified under NAICS Code 541715, which pertains to Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and uses Product Service Code AN13. The primary place of performance is the District of Columbia, United States. This opportunity is open to all interested parties capable of delivering innovative research and development solutions in the specified domain. There are no explicit set-aside requirements or special considerations noted in the provided information. Contractors should review the attached solicitation documents for detailed instructions, requirements, and evaluation criteria. The contracting entity for this solicitation is ARPA-H, a federal office within the Department of Health and Human Services. All inquiries and proposal submissions should be directed to the FASTPASS Team at [email protected]. The solicitation was posted on October 21, 2026, with responses due by November 10, 2026. The notice remains active and can be accessed via the official SAM.gov portal at https://sam.gov/opp/1479442e64d740b59cc92c717bd329bc/view. Contractors with expertise in AI-enabled screening technologies, supply chain security, and pharmaceutical product assessment are encouraged to evaluate this opportunity for alignment with their capabilities and strategic objectives.
Documents14